arrow
Back
M

Mark Roschewski

national cancer institute

40H-index
288Paper Count
9.4KCitation Count
Published Papers 55
Publication Date
A phase 1 trial of romidepsin, azacitidine, dexamethasone and lenalidomide in relapsed or refractory T-cell lymphoma
err2026-02-16
err0
errOAAI
errMax J. Gordon; Milos D. Miljkovic; Paige Milhon; Rahul Lakhotia; Christopher Melani; Kim Johnson; Bonita Bryant; Stefania Pittaluga; Elaine S. Jaffe; Kevin Conlon; Louis M. Staudt; Wyndham H. Wilson; Mark Roschewski; Samuel Ng
errShare
errSave
Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non-Hodgkin lymphoma
err2025-10-30
err0
errOAAI
errMax J. Gordon; Rahul Lakhotia; Stefania Pittaluga; Svetlana D. Pack; Anna Marie Juanitez; Ahmed Hamdy; Amy J. Johnson; Melanie M. Frigault; Raquel Izumi; Mark Raffeld; Mark Roschewski; Wyndham H. Wilson; Christopher Melani
errShare
errSave
Acute Transient Aminotransferase Elevation is Common With Intrathecal Methotrexate, but Liver Injury is Infrequent
err2025-02-10
err0
errOAAI
errGopalakrishna, Harish; Hercun, Julian; Shah, Nirali N.; Roschewski, Mark; Rotman, Yaron
errShare
errSave
errShare
errSave
Multi- Component, Time- Course screening to develop combination cancer therapies based on synergistic toxicity
err2024-11-25
err0
PREAI
errCeribelli, Michele; Tosto, Frances Anne; Zhang, Xiaohu; Melani, Christopher J.; Roschewski, Mark; Beck, Erin; Thomas, Carleen Klumpp -; Peer, Cody J.; Wilson, Kelli M.; Chen, Lu; Mcknight, Crystal; Michael, Sam; Itkin, Zina; Shinn, Paul; Figg Sr, William D.; Wilson, Wyndham H.; Staudt, Louis M.; Thomas, Craig J.
errShare
errSave
Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma
err2024-11-15
err0
errOAAI
errMaakaron, Joseph E.; Asch, Adam; Popplewell, Leslie; Collins, Graham P.; Flinn, Ian W.; Ghosh, Nilanjan; Keane, Colm; Ku, Matthew; Mehta, Amitkumar; Roschewski, Mark; Hacohen-Kleiman, Gal; Huo, Yanan; Zhang, Yi; Renard, Camille; Smith, Sonali M.; Advani, Ranjana
errShare
errSave
The Clinical Impact and Cost-Effectiveness of PET-Based and Ctdna-Based Evaluation at End-of-Therapy after Frontline Treatment of DLBCL
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errKambhampati, Swetha; Goldstein, Jordan S.; Buller, Seth; Roschewski, Mark; Alizadeh, Ash A.; Thiruvengadam, Nikhil
errShare
errSave
A Phase 2 Response-Adapted Study of Daratumumab, Carfilzomib, and Dexamethasone (DKd) in Patients with High-Risk Smoldering Multiple Myeloma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errPatel, Roshani; Bhaskarla, Amrit; Gordon, Max J.; Emanuel, Michael; Colon, Dana I. Delgado; Wang, Hao-Wei; Yuan, Constance M.; Lindenberg, Liza; Mena, Esther; Turkbey, Baris; Micheletti, Nick; Yee, Laura M.; Patel, Nisha; Maric, Irina; Braylan, Raul C.; Calvo, Katherine R.; Staudt, Louis M.; Young, Ryan M.; Roschewski, Mark; Kazandjian, Dickran; Hill, Elizabeth
errShare
errSave
Phase lb/2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed/Refractory and Treatment-Naive Mantle Cell Lymphoma: Preliminary Analysis of Safety, Efficacy, and Minimal Residual Disease
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errMelani, Christopher; Lakhotia, Rahul; Pittaluga, Stefania; Phelan, James D.; Muppidi, Jagan R.; Gordon, Max J.; Yang, Yandan; Xu, Weihong; Davies-Hill, Theresa; Huang, Da Wei; Thomas, Craig J.; Ceribelli, Michele; Tosto, Frances A.; Juanitez, Anna M.; Pradhan, Amynah; Morrison, Candis; Tadese, Atekelt; Ramsower, Colleen; Rimsza, Lisa M.; Jacob, Allison P.; Simmons, Heidi; Steinberg, Seth M.; Jaffe, Elaine S.; Roschewski, Mark; Staudt, Louis M.; Wilson, Wyndham H.
errShare
errSave
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
err2024-06-20
err5
errOAAI
errMelani, Christopher; Lakhotia, Rahul; Pittaluga, Stefania; Phelan, James D.; Huang, Da Wei; Wright, George; Simard, Jillian; Muppidi, Jagan; Thomas, Craig J.; Ceribelli, Michele; Tosto, Frances A.; Yang, Yandan; Xu, Weihong; Davies-Hill, Theresa; Pack, Svetlana D.; Peer, Cody J.; Arisa, Oluwatobi; Mena, Esther; Lindenberg, Liza; Bergvall, Ethan; Portell, Craig A.; Farah, Rafic J.; Lee, Seung Tae; Pradhan, Amynah; Morrison, Candis; Tadese, Atekelt; Juanitez, Anna Marie; Lu, Crystal; Jacob, Allison; Simmons, Heidi; Figg, William D.; Steinberg, Seth M.; Jaffe, Elaine S.; Roschewski, Mark; Staudt, Louis M.; Wilson, Wyndham H.
errShare
errSave
BTK drives neutrophil activation for sterilizing antifungal immunity
err2024-05-02
err5
errOAAI
errDesai, Jigar, V; Zarakas, Marissa A.; Wishart, Andrew L.; Roschewski, Mark; Aufiero, Mariano A.; Donko, Agnes; Wigerblad, Gustaf; Shlezinger, Neta; Plate, Markus; James, Matthew R.; Lim, Jean K.; Uzel, Gulbu; Bergerson, Jenna R. E.; Fuss, Ivan; Cramer, Robert A.; Franco, Luis M.; Clark, Emily S.; Khan, Wasif N.; Yamanaka, Daisuke; Chamilos, Georgios; El-Benna, Jamel; Kaplan, Mariana J.; Staudt, Louis M.; Leto, Thomas L.; Holland, Steven M.; Wilson, Wyndham H.; Hohl, Tobias M.; Lionakis, Michail S.
errShare
errSave
Circulating tumor DNA and nivolumab maintenance: A pilot study in diffuse large B cell lymphoma
err2024-04-05
err0
PREAI
errNakhoda, Shazia; Sklarz, Tamarrah; Pagan, Cheyenne; Matasar, Matthew; Frosch, Zachary A.; Messmer, Marcus; Yanovsky, Asya Varshavsky; Khanal, Rashmi; Tan, Carlyn; Mikkelsen, Eli; Fung, Henry; Ross, Eric; Roschewski, Mark; Jacob, Allison; Khan, Nadia
errShare
errSave
Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R
err2023-09-14
err0
errOAAI
errLakhotia, Rahul; Dunleavy, Kieron; Abramson, Jeremy S.; Link, Brian K.; Powell, Bayard L.; Melani, Christopher; Lucas, Andrea N.; Steinberg, Seth M.; Friedberg, Jonathan W.; Kahl, Brad S.; Little, Richard F.; Bartlett, Nancy L.; Noy, Ariela; Wilson, Wyndham H.; Roschewski, Mark
errShare
errSave
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment
err2023-06-26
err10
errOAAI
errRoschewski, Mark; Patel, Manish R.; Reagan, Patrick M.; Saba, Nakhle S.; Collins, Graham P.; Arkenau, Hendrik-Tobias; de Vos, Sven; Nuttall, Barrett; Acar, Melih; Burke, Kathleen; White, Rafael D.; Udriste, Maria; Sharma, Shringi; Dougherty, Brian; Stetson, Daniel; Jenkins, David; Mortlock, Andrew; Forcina, Alessandra; Munugalavadla, Veerendra; Flinn, Ian
errShare
errSave
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial
err2023-05-01
err5
PREAI
errMelani, Christopher; Dowdell, Kennichi; Pittaluga, Stefania; Dunleavy, Kieron; Roschewski, Mark; Song, Joo Y.; Calattini, Sara; Kawada, Jun-ichi; Price, David A.; Chattopadhyay, Pratip K.; Roederer, Mario; Lucas, Andrea N.; Steinberg, Seth M.; Jaffe, Elaine S.; Cohen, Jeffrey, I; Wilson, Wyndham H.
errShare
errSave
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment
err2023-02-17
err6
errOAAI
errLai, Catherine; Cole, Diane E.; Steinberg, Seth M.; Lucas, Nicole; Dombi, Eva; Melani, Christopher; Roschewski, Mark; Balis, Frank; Widemann, Brigitte C.; Wilson, Wyndham H.
errShare
errSave